Posts by ericg
The Petri Dish: Neumora hires Amgen R&D head; Brigham and Women’s scientists launch startup
Two Brigham and Women’s scientists teamed up to commercialize a technology they developed in Boston: nasal sprays that, they say, block and remove inhaled airborne contaminants for up to eight hours. Plus other life sciences news you may have missed. Read More
Read MoreCIA’s investment arm backs Littleton cooling tech startup
JetCool Technologies, which is working to address the heat, water and electricity consumption in data centers, has a new investor: In-Q-Tel, known as "the CIA’s venture-capital firm." Read More
Read MoreLab construction starts in Greater Boston are falling fast
Blame industry layoffs and funding challenges, as well as high interest rates and slow leasing in the many projects that have hit the market recently. Read More
Read MoreBiotech VC slump continues in Q3, says report
The markets are still stacked against startups in the American biotech sector, per a new report from PitchBook and the National Venture Capital Association. Read More
Read MoreFive things: Signs on Boston’s skyline and a struggle to process Israeli attacks
Good morning. Here are the five things you need to know in Boston business news, including Boston’s changing skyline, and a struggle to process the brutal Israeli attacks. Read More
Read MoreNational Beat: Air taxis are coming, and cities aren’t ready
The age of flying taxis is a lot closer than people may expect, and cities aren’t ready for it, experts say. Read More
Read MoreFDA warns Abiomed over device classification
In a warning letter dated Sept. 19 that was made public on Tuesday, the agency slammed Abiomed for classifying certain software functions of its Impella Connect system as "non-device clinical decision support" rather than a medical device. Read More
Read MoreBizSpotlight: Eastport Real Estate Services
Lowell, MA – October, 2023 – Eastport Real Estate Read More
Read MoreCorporate names, logos abound on the new Boston skyline
Prudential’s name used to be one of the only corporate brands atop a tower in or around Boston. That’s far different today, with four notable new signs going up this year alone. Here’s a look. Read More
Read MoreA Boston biotech raised new funding — and moved to Colorado
A Boston biotech has raised new capital and is preparing to scale, including with its first clinical trial for an early detection test for ovarian cancer. But even though the company has its roots in Boston, its next stage of growth will not be focused on the city. Read More
Read More